Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimates.
Xaquin Castro DopicoSandra MuschiolNastasiya F GrinbergSoo AlemanDaniel J ShewardLeo HankeMarcus AhlLinnea VikströmMattias N E ForsellJonathan M CoquetGerald M McInerneyJoakim DillnerGordana BogdanovicBen MurrellJan AlbertChris WallaceGunilla B Karlsson HedestamPublished in: Clinical & translational immunology (2022)
Probabilistic antibody testing frameworks can improve seropositivity estimates in populations with large titer variability.